BLU 300 Pill - white capsule/oblong, 18mm
Generic Name: avapritinib
Pill with imprint BLU 300 is White, Capsule/Oblong and has been identified as Ayvakit 300 mg. It is supplied by Blueprint Medicines Corporation.
Ayvakit is used in the treatment of Systemic Mastocytosis; Gastrointestinal Stromal Tumor and belongs to the drug class multikinase inhibitors. Ayvakit 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BLU 300
Ayvakit
- Generic Name
- avapritinib
- Imprint
- BLU 300
- Strength
- 300 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Blueprint Medicines Corporation
- National Drug Code (NDC)
- 72064-0130
See also:
Prilosec
Prilosec (omeprazole) is used to treat symptoms of GERD and other conditions caused by excess ...
Prevacid
Prevacid is used to treat and prevent stomach and intestinal ulcers. Learn about side effects ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Stivarga
Stivarga (regorafenib) is used to treat metastatic colorectal cancer, gastrointestinal stromal ...
Gastrocrom
Gastrocrom is used for inflammatory bowel disease, systemic mastocytosis
Sutent
Sutent is a cancer medicine that is used to treat certain types of advanced or progressive tumors ...
Qinlock
Qinlock (ripretinib) is used for the treatment of patients with advanced gastrointestinal stromal ...
More about Ayvakit (avapritinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.